Loading...
Market
Next major publication featuring UCSF's metagenomic test by end of 2025?
2
Resolution / Starting Odds
Nature Medicine • 25%
The Lancet • 25%
JAMA • 25%
Other • 25%
Publication records and announcements
Story
UCSF's Metagenomic Test Achieves 86% Accuracy in CNS Infection Diagnosis in Thousands Over Seven Years, Published in Nature Medicine
Nov 12, 2024, 03:40 PM
A clinical metagenomic next-generation sequencing test developed at the University of California, San Francisco (UCSF) has demonstrated a seven-year performance in diagnosing central nervous system infections. The test has been validated in thousands of patients, showing an accuracy rate of 86% in identifying diverse pathogens. This advancement is significant for improving patient care in neurological infections and enhancing detection capabilities for pandemic threats. The findings were reported in prominent medical journals, including Nature Medicine and Nature Communications.
View original story
Similar markets
Guardant Reveal • 25%
Guardant360 • 25%
GuardantOMNI • 25%
None • 25%
ADHD • 25%
Schizophrenia • 25%
Bipolar Disorder • 25%
Parkinson’s Disease • 25%
Nature • 25%
Science • 25%
Cell • 25%
Other • 25%
Yes • 50%
No • 50%
Cancer Research • 25%
Neurological Disorders • 25%
Genetic Disorders • 25%
Other • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Positive results for Shield • 25%
Positive results for Reveal • 25%
Positive results for Guardant360 • 25%
No positive results • 25%
Elephant genome • 25%
Blue whale genome • 25%
Komodo dragon genome • 25%
Other • 25%